> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Class 2 for Meprobamate Test System
- URL: https://www.fdaweb.com/class-2-for-meprobamate-test-system/
- Published: 2018-11-01T12:00:00.000Z
- Updated: 2026-09-15T00:42:04.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142721

*Federal Register* notice: FDA has classified the meprobamate test system into Class 2 (special controls). The action follows a 2/2017 de novo classification request from Lin-Zhi International for its LZI Carisoprodol Metabolite (Meprobamate) Enzyme Immunoassay. The device is identified as being intended to measure meprobamate in human specimens. Measurements obtained by this device are used to detect the presence of meprobamate to diagnose the use or overdose of meprobamate or structurally-related drug compounds (e.g., prodrugs). To view the notice, click [here](https://www.gpo.gov/fdsys/pkg/FR-2018-11-01/pdf/2018-23911.pdf?ref=fdaweb.com).